Strides Pharma to acquire Endo’s manufacturing facility at New York

INDIA – Strides Pharma Science has announced that its wholly owned subsidiaries have entered into definitive agreements with subsidiaries of Endo International to acquire its manufacturing facility in New York and a basket of ANDAs. The drug company signed definitive agreement with Endo to acquire its manufacturing facility in the US along with basket of ANDAs. The proposed acquisition will further bolster Strides’ US presence through acquisition of a multi dosage facility in the US and a basket of ANDAs cutting across multiple therapeutic segments. The cumulative addressable market for…

Read More